Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease

US Patent 8940722 · Granted Jan 27, 2015

Assignee

Inventors

View full patent text on Google Patents →